Lukana Preechasuk1, Nattakarn Suwansaksri1, Nantawan Ipichart1, Sathit Vannasaeng1, Chairat Permpikul2, Apiradee Sriwijitkamol3. 1. Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, 10700. 2. Division of Critical Care, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, 10700. 3. Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, 10700. Electronic address: apiradeesi99@hotmail.com.
Abstract
PURPOSE: The purpose was to compare glucose variability (GV) obtained via continuous glucose monitoring between nondiabetic sepsis patients and healthy subjects and to seek associations between GV and sepsis severity in nondiabetic sepsis patients. METHODS: Nondiabetic sepsis inpatients and healthy controls received a 72-hour continuous glucose monitoring (iPro2, Medtronic) postadmission and post-oral glucose tolerance test, respectively. The mean glucose level (MGL) along with GV represented by standard deviation (SD) and the mean amplitude of glycemic excursion (MAGE) were calculated at 24 and 72 hours. Sepsis severity was evaluated with the Sepsis-related Organ Failure Assessment Score (SOFA). MGL and GV in patients with SOFA ≥9 and <9 were compared. RESULTS: Thirty nondiabetic sepsis and 10 healthy subjects were recruited. No differences were found between groups except for higher patient age in sepsis patients. The MGL and MAGE72h of sepsis patients were significantly higher than those of healthy subjects. MGL and GV24h were higher in patients with SOFA ≥9 than in patients with SOFA <9 (MGL24h 195±17 vs 139±27, P<.001; SD24h 32 [28, 36] vs 19 [5, 58], P=.02; and MAGE24h 94 [58, 153] vs 54 [16, 179], P=.01). CONCLUSION: Nondiabetic sepsis patients had higher MGL and GV values than healthy subjects. MGL and GV24h were associated with sepsis severity.
PURPOSE: The purpose was to compare glucose variability (GV) obtained via continuous glucose monitoring between nondiabetic sepsispatients and healthy subjects and to seek associations between GV and sepsis severity in nondiabetic sepsispatients. METHODS:Nondiabetic sepsis inpatients and healthy controls received a 72-hour continuous glucose monitoring (iPro2, Medtronic) postadmission and post-oral glucose tolerance test, respectively. The mean glucose level (MGL) along with GV represented by standard deviation (SD) and the mean amplitude of glycemic excursion (MAGE) were calculated at 24 and 72 hours. Sepsis severity was evaluated with the Sepsis-related Organ Failure Assessment Score (SOFA). MGL and GV in patients with SOFA ≥9 and <9 were compared. RESULTS: Thirty nondiabetic sepsis and 10 healthy subjects were recruited. No differences were found between groups except for higher patient age in sepsispatients. The MGL and MAGE72h of sepsispatients were significantly higher than those of healthy subjects. MGL and GV24h were higher in patients with SOFA ≥9 than in patients with SOFA <9 (MGL24h 195±17 vs 139±27, P<.001; SD24h 32 [28, 36] vs 19 [5, 58], P=.02; and MAGE24h 94 [58, 153] vs 54 [16, 179], P=.01). CONCLUSION:Nondiabetic sepsispatients had higher MGL and GV values than healthy subjects. MGL and GV24h were associated with sepsis severity.
Authors: Johanna S Dutton; Samuel S Hinman; Raehyun Kim; Peter J Attayek; Mallory Maurer; Christopher S Sims; Nancy L Allbritton Journal: Integr Biol (Camb) Date: 2021-06-15 Impact factor: 2.192
Authors: María Paula Russo; Santiago Nicolas Marquez Fosser; Cristina María Elizondo; Diego Hernán Giunta; Nora Angélica Fuentes; María Florencia Grande-Ratti Journal: Rev Diabet Stud Date: 2021-11-01